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Abstract The amphiphilic polypeptide polyproline having dif-
ferent chain lengths was connected to the C-terminus of human 
lysozyme by the recombinant DNA technique. The hydrophobic-
ity of human lysozyme increased with increasing length of the 
polyproline chain. Although the bactericidal activity of wild-type 
lysozyme is limited to Gram-positive bacteria and the hydrolytic 
activity of the mutant lysozyme decreased with increasing chain 
length of polyproline, the mutant lysozymes showed bactericidal 
activity to Gram-negative bacteria and the activity increased 
with increasing hydrophobicity of the mutant enzyme. Experi-
ments with Escherichia coli phospholipid liposomes revealed that 
the mutant human lysozymes dissipated the valinomycin-induced 
transmembrane electrochemical potential, and the dissipation 
increased with increasing hydrophobicity. The increased hydro-
phobicity of the mutant enzyme may induce interaction of 
lysozyme with the outer membrane and subsequent penetration 
into the inner membrane of E. coli, resulting in an increase of 
bactericidal activity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The antibacterial activity of lysozyme is limited to Gram-
positive bacteria. The enzyme catalyzes the hydrolysis of the 
ß-(l,4)-glycosidic linkage between iV-acetylmuramic acid and 
./v-acetylglucosamine of the peptidoglycan in the bacterial cell 
wall [1], interacts with the lipopolysaccharide (LPS) layer in 
the outer membrane [2], and subsequently distorts the normal 
packing between phosphate groups of phospholipids and LPS 
by its polycationic properties [3]. The distortion results in 
perturbation of the structure of the outer membrane and stim-
ulation of the susceptibility to peptidoglycan layer [4]. Despite 
its action on the outer membrane, lysozyme does not affect 
the viability of Gram-negative bacteria, while the same actions 
lead to lethality of Gram-positive bacteria. 
However, Kato and coworkers reported that the covalent 
attachment of palmitic acid residue to the lysyl residue of hen 
egg-white lysozyme or the fusion of a hydrophobic pentapep-
tide (Phe-Phe-Val-Ala-Pro), which can form a ß-strand con-
formation having the same length as the palmitic acid residue, 
to its C-terminus had bactericidal activity against Escherichia 
coli [5-7]. Nakamura et al. reported that the lysozyme-pal-
mitic acid conjugate protected fish from infection with E. 
tarda [8]. They considered that the short hydrophobic chains 
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promoted the penetration of the lysozyme molecule into the 
inner membranes of Gram-negative bacteria. 
In this investigation, human lysozymes having different hy-
drophobicities were synthesized by gene-engineered attach-
ment of polyproline chains at the carboxyl end of the enzyme 
and the bactericidal activities were investigated. 
2. Materials and methods 
2.1. Materials 
The plasmid containing cDNA for human lysozyme [9] was kindly 
given by Takeda Chem. Ind. Ltd. (Osaka, Japan). Oligodeoxyribonu-
cleotides used in the present investigation were synthesized by Sawady 
Technol. Co. (Tokyo, Japan). Micrococcus luteus cells were purchased 
from Sigma Co. (St. Louis, MO, USA). 
2.2. Construction of expression plasmid of mutant human lysozyme 
A primer 5'-GGT-GTT-GCC-CGG-GTC-GAC-CCG-GTC-GAC-
3' was used to introduce a Smal endonuclease site instead of the 
stop codon of human lysozyme into pLY plasmid by site-directed 
mutagenesis. 
Four primers, 5'-AAT-TCT-CAG-TCA-TCC-CGG-GGG-GCC-
CAC-CAC-CAC-CAC-3', 5'-CAC-CAC-CAC-CAC-CAC-CAT-
AAT-AGG-TCG-ACC-GAC-CTG-TGC-TCA-3', 5'-TGG-TGG-
TGG-TGG-TGG-TGG-GCC-CCC-CGG-GAT-GAC-TGA-G-3', 
and 5'-AGC-TTG-AGC-ACA-GGT-CGG-TCG-ACC-TAT-TAT-
GGT-GGT-GGT-GG-3', were annealed to form double strand 
DNA fragments encoding 10 residues of proline and the stop codon. 
Subsequently, the DNA fragments were annealed in the presence of 
pUC19 digested with EcoRI and Hindlll and were ligated to con-
struct pPRlO plasmid. The pPRlOa plasmid encoding 10 residues of 
proline without the stop codon was constructed similarly. The pPR20 
plasmid encoding 20 proline residues was constructed by insertion of 
the proline region into the pPRlOa plasmid upstream of the pPRlO 
plasmid. The pPR30 plasmid was also constructed similarly. The con-
struction of the plasmids was confirmed by electrophoresis and DNA 
sequencing. 
pLY was digested with Smal and Sah endonucleases. The pPRlO, 
pPR20 and pPR30 plasmids were digested with Apal, a blunting kit 
(Takara, Japan) and finally San. pLY-polyproline, which is the plas-
mid DNA encoding human lysozyme carrying polyproline, was con-
structed by ligation reaction. The construction of the plasmids was 
confirmed by electrophoretic analysis and DNA sequencing. 
2.3. Expression of mutant human lysozymes 
Lysozymes carrying various lengths of polyproline chain at the 
carboxyl end were expressed in Saccharomyces cerevisiae AH22 
(MATa, his3, leu2) with pLY-pPR10, PLY-pPR20, or pLY-pPR30 
plasmid. The human lysozymes carrying a polyproline chain consist-
ing of 10, 20 or 30 residues at the carboxyl end were secreted because 
the plasmids contained a signal sequence [9]. 
2.4. Purification of mutant human lysozymes 
The transformed yeast cells were precultivated in 100 ml of YPD 
(1% yeast extract, 1% peptone, 2% glucose) medium for 16 h and 
cultivated in 4 1 of Burkholder medium for 4 days at 30°C. Cells in 
the late exponential phase were removed by centrifugation at 1700Xg 
for 10 min and the medium having secreted proteins was concentrated 
to 400 ml by ultrafiltration using an AMICON model 2000 (Massa-
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chusetts, USA). The concentrate was loaded onto a CM-Toyopearl 
650 C (Tosoh, Japan) column pre-equilibrated with 50 mM sodium 
phosphate buffer (pH 6.5). After washing with 3 bed volumes of the 
same buffer, adsorbed protein was eluted in 50 mM sodium phosphate 
buffer (pH 6.5) containing 0.5 M NaCl and 10% glycerol. The active 
fractions were pooled and concentrated to 1 ml by ultrafiltration. Gel 
permeation Chromatographie analysis was performed using a COS-
MOSIL 5Diol column (Nacalai Tesque, Kyoto, Japan) (20 mM phos-
phate buffer (pH 7.0)+0.1 M sodium sulfate at a rate of 1.0 ml/min). 
2.5. Estimation of hydrophobicity 
Hydrophobie chromatography was carried out using a TSKgel phe-
nyl-5PW (Tosoh, Japan) column (linear gradient from 0.5 M phos-
phate-buffered solution (pH 7.0)+2.0 M ammonium sulfate solution 
to 0.5 M phosphate-buffered solution (pH 7.0) over 60 min at a rate 
of 1.0 ml/min). 
2.6. Assay of hydrolytic activity 
Hydrolytic activity was determined by hydrolysis of p-nitrophenyl 
tri-7V-acetyl-ß-chitotrioside. The substrate (6 mM) was dissolved in 0.5 
ml of 40 mM citric acid buffer solution (pH 5.08) containing 10% of 
dioxane. The solution was incubated at 40°C for 3 min followed by 
addition of the lysozyme solution. The absorbance of p-nitrophenol 
released was monitored at 405 nm. 
Fig. 1. Analysis of mutant human lysozymes by SDS-PAGE. Lane 
a: marker proteins; b : wild-type human lysozyme; c: mutant hu-
man lysozyme carrying 10 proline residues; d: mutant human lyso-
zyme carrying 20 prolines residues; e: mutant human lysozyme car-
rying 30 proline residues. 
2.7. Assay of bactericidal activity 
The suspension of M. lut eus cell (1 mg/ml) was mixed with lysozyme 
in phosphate buffer (pH 6.2, 7=0.04). The mixture was incubated at 
25°C for 3 min. Ionic strength was adjusted with NaCl. The decrease 
of absorbance at 450 nm was measured. The activity of wild-type 
human lysozyme was taken as 100%. 
The suspension of E. coli DH5oc cells (105 cells/ml) was mixed with 
lysozyme (final concentration, 12 ng/ml) in 50 mM phosphate buffer 
solution (pH 7.0). The mixture was incubated at 37°C for 60 min and 
a diluted portion (50 ul) was pipetted out and plated onto LB agar 
plates. After incubation of the plates at 37°C overnight, the number of 
colonies was counted. The activity of wild-type human lysozyme was 
taken as 100%. 
2.8. Measurements of membrane potential of E. coli phospholipid 
liposomes 
Phospholipids were isolated from E. coli according to the method of 
Viitanen et al. [10]. The liposome was prepared by an extruder (Lipex 
Biomembrane Inc., Vancouver, Canada) through a series of polycar-
bonate membrane filters (Nucleopore Corp., Pleasanton, CA, USA). 
The potential was determined by measuring the fluorescence quench-
ing of 3,3'-dipropylthiodicarbocyanine iodide [diS-C3-(5)] using a Hi-
tachi fluorescence spectrophotometer by the method reported by Kita 
et al. [11]. 
3. Results 
3.1. Production of mutant human lysozymes 
The purified lysozymes were analyzed by gel permeation 
chromatography. The mutant human lysozymes had a single 
peak in the elution profile. The analysis of amino acid com-
position showed that the mutant human lysozyme carrying 30 
proline residues at the C-terminus had an alanine residue and 
30 proline residues as designed in the recombinant gene. In 
addition, they were analyzed by SDS-polyacrylamide gel elec-
trophoresis (Fig. 1). The band positions of mutant human 
lysozymes were higher than expected. However, mass spec-
troscopy measurement demonstrated that the molecular 
weight of mutant human lysozyme carrying 30 proline resi-
dues was the same as the calculated mass (1.76 X 104 Da). It is 
known that hydrophobic proteins have unusual affinity for 
SDS because SDS-protein interaction forces are mainly hy-
drophobic [12,13]. Therefore SDS binding to the mutant hu-
man lysozyme should reduce the electrophoretic migration. 
3.2. Hydrophobicity of mutant human lysozymes 
The hydrophobicity of mutant human lysozyme was inves-
tigated by hydrophobic chromatography (Fig. 2). The elution 
time was increased with increasing length of the proline chain 
and approached that of homo-polyproline. 
3.3. Hydrolytic activity of mutant human lysozymes 
Hydrolytic activity of mutant human lysozymes was re-
duced by connection of proline residues to the C-terminal 
(Table 1). Although Km was not significantly affected by the 
mutation, &cat decreased with increasing length of the poly-
proline tail. However, the mutant human lysozyme carrying 
30 proline residues catalyzed hydrolysis of more hydrophobic 
(less water-soluble) substrate, penta-N-acetyl-ß-chitopenta-
oside (21%) more than that of tri-TV-acetyl-ß-chitotrioside 
(11%), compared with wild-type human lysozyme. The hydro-
phobic mutant human lysozyme was considered to easily ac-
cess the hydrophobic substrate. 
Table 1 
Hydrolysis of /7-nitrophenyl tri-JV-acetyl-ß-chitotrioside (Tri) and /)-nitrophenyl penta-/V-acetyl-ß-chitopentaoside (Penta), and bactericidal activ-
ity against Gram-positive and Gram-negative bacteria by various human lysozymes 
Enzyme 
Wild-type 
Mutant 
Number of 
proline residues 
in the C-terminal 
0 
10 
20 
30 
Tri 
Relative 
(%) 
100 
81 
37 
11 
activity Km 
(mM) 
2.27 
2.26 
2.27 
2.20 
^cat 
(min -1) 
2.31 
1.82 
0.77 
0.23 
Penta 
Relative 
(%) 
100 
-
-
21 
activity 
Bactericidal 
Gram-
(%) 
100 
81 
38 
11 
activity 
-positive Gram-negative 
(%) 
100 
106 
122 
206 
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3.4. Bactericidal activity of mutant human lysozymes 
Table 1 shows that although the bactericidal activity of 
mutant human lysozyme to Gram-positive bacteria was re-
duced with increasing length of the polyproline tail, the effect 
on Gram-negative bacteria (E. coli) was enhanced. The in-
crease of hydrophobicity might increase the activity against 
Gram-negative bacteria. 
Davies et al. [14] and Saint-Blancard et al. [15] reported 
that the bactericidal activity of wild-type lysozyme depended 
on the ionic strength. The activity of mutant lysozyme also 
depended on the ionic strength, although the optimum ionic 
strength of mutant human lysozyme was slightly different 
from that of wild-type human lysozyme (Fig. 3). 
3.5. Interaction with liposome 
The effect of mutant human lysozymes on the fluorescence 
quenching of diS-C3-(5) by valinomycin in the E. coli phos-
pholipid liposome was investigated. The addition of mutant 
human lysozymes to the liposomes hyperpolarized by valino-
mycin reversed the fluorescence quenching, but the addition of 
wild-type human lysozyme at the same concentration had no 
effect on the signal. The reversal of the fluorescence quenching 
by mutant human lysozymes may reflect their ability to dis-
37.52 
a) wild-type lysozyme 
43.28 
b) lysozyme-plO 
c) lysozyme-p20 
d) lysozyme-p30 
polyproline 
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Fig. 2. Elution profile of mutant human lysozymes in the hydropho-
bic chromatography. a: Wild-type human lysozyme; b: mutant hu-
man lysozyme carrying 10 proline residues (lysozyme-plO); c: mu-
tant human lysozyme carrying 20 proline residues (lysozyme-p20); 
d: mutant human lysozyme carrying 30 proline residues (lysozyme-
p30); e: polyproline (8 kDa). 
0.00 0.02 0.04 0.06 0.08 0.10 
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Fig. 3. Influence of ionic strength on the lysis of M. luteus cells by 
wild-type (■) and mutant human lysozymes carrying 30 proline resi-
dues (o) at pH 6.2. Maximal activity of each human lysozyme is 
represented as 100%. 
rupt the electrochemical potential. The increasing length of 
the polyproline tail increased the reversion and the significant 
collapse of the membrane potential in a way similar to the 
addition of nigericin. Taking into consideration that neither 
polyproline nor lysozyme affected the membrane potential, 
the combination of human lysozyme and hydrophobic poly-
proline is indispensable to affect the membrane potential. 
4. Discussion 
Various types of antimicrobial peptides, including post-
translationally modified peptides, have been found and these 
peptides have characteristic secondary structure or amino acid 
composition [16-18]. A group of peptides, including cecro-
pins, magainins, and mellithitin, take an cc-helical structure 
in lipid membrane. The oc-helical structure has been found 
in many other antimicrobial peptides [19,20]. On the other 
hand, peptides having an antiparallel ß-sheet structure are 
known [21]. Some peptides contain a high percentage of spe-
cific amino acids such as the proline- or arginine-rich bovine 
peptides, Bac 5 and Bac 7 [22], the porcine peptide PR-39 [23], 
and the tryptophan- or proline-rich peptide indolicidin [24,25], 
tryptophan-rich peptide [26]. Recently Falla et al. [24] re-
ported that indolicin has a weak poly(L-proline)-II-type ex-
tended helix structure. Skelavaj et al. [27] reported that two 
novel cathelicidin-derived peptides having a cationic N-termi-
nal region and an amphipathic a-helical conformation fol-
lowed by a hydrophobic C-terminal tail had antimicrobial 
activity. 
In the present investigation, the proline residues may form a 
polyproline helix structure to result in increased hydrophobic-
ity. Considering that the pK& of human lysozyme is 11 [28], 
the protein is positively charged under neutral conditions. A 
perturbation of membrane potential by the mutant human 
lysozymes should occur either by the hydrophobic interaction 
of the polyproline tail with lipid membrane or by electrostatic 
interaction between the positively charged groups of the lyso-
zyme molecule and the anionic polar heads of the phospho-
lipids of the membrane. The physico-chemical property rather 
than the hydrolytic activity of the mutant lysozymes should 
have a greater contribution to the bactericidal activity, taking 
288 Y. Ito et allFEBS Letters 415 (1997) 285-288 
into account that the mutant human lysozymes had very low 
activity. The ability of mutant lysozymes to damage the cell 
membrane may account for their bactericidal action to E. coli. 
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